Georgia Life Sciences Names Renee' Martin, Ph.D., Program Manager to Lead Flagship Educator Workforce Development Program

FOR IMMEDIATE RELEASE


July 21, 2026 (ATLANTA, Ga) – Georgia Life Sciences (GLS) has named Renee' Martin, Ph.D. as Program Manager for its Teacher Training Initiative, one of the state's most established educator workforce development programs designed to prepare middle and high school teachers to introduce students to careers across Georgia's growing life sciences industry.

 

Now entering its eighth year, the initiative has trained 959 educators who have collectively reached nearly 300,000 students across Georgia. Approximately 70% of participating teachers serve Title I schools, helping expand access to high-quality life sciences education and career exploration in communities throughout the state.

 

In her new role, Martin will lead the Teacher Training Initiative, a longstanding partnership with the Georgia Department of Education that equips educators with industry knowledge, classroom resources, hands-on laboratory experiences, and connections to Georgia's life sciences ecosystem. She will also oversee the Georgia Life Sciences Equipment Depot, which provides donated laboratory equipment and educational resources to classrooms across the state.

 

"Preparing Georgia's future life sciences workforce begins by investing in our educators," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "Renee' brings an exceptional combination of classroom experience, educator leadership, and a deep understanding of Georgia's education system. Her experience supporting teachers across the state, combined with her passion for workforce development, makes her uniquely positioned to lead this important initiative as we continue expanding opportunities that connect educators, students, and Georgia's life sciences ecosystem."

 

A seasoned educator with a solid track record in agricultural and STEM education, Martin has taught and supported students and teachers across Georgia and most recently served with a Georgia Regional Educational Service Agency (RESA), where she worked with educators to strengthen instructional practices and student outcomes.

 

She earned her Ph.D. in Agricultural Leadership, Education and Communication from the University of Georgia, where her work focused on agricultural education, educator development, and workforce preparation.

 

Beyond her professional experience, Martin has demonstrated a strong commitment to leadership and service through numerous roles with the University of Georgia Graduate Student Association, Designated Dawgs, the Association for International Agricultural and Extension Education (AIAEE), and other community and professional organizations.

 

"I am honored to join Georgia Life Sciences and contribute to a program that is making a meaningful difference for educators and students across Georgia," said Martin. "Teachers play a vital role in helping students discover new opportunities and envision future careers. I look forward to working with educators and industry partners to strengthen those connections and inspire the next generation of Georgia's life sciences workforce."

 

Martin joins Georgia Life Sciences as the organization continues to expand its statewide workforce development efforts to meet the talent needs of Georgia's rapidly growing life sciences sector. Through educator training, industry partnerships, classroom resources, career awareness initiatives, and the Georgia Life Sciences Equipment Depot, the organization is helping build the skilled workforce that will power Georgia's future economy.

 

Additional information about the Georgia Life Sciences Teacher Training Initiative is available at www.galifesciences.org.

 

About Georgia Life Sciences

Georgia Life Sciences is the state's leading life sciences membership organization, representing biotechnology, biopharmaceutical, medical device, diagnostics, research, and life sciences service companies, along with academic institutions and ecosystem partners. Through advocacy, workforce development, and industry engagement, Georgia Life Sciences works to advance innovation, strengthen Georgia's life sciences economy, and develop the talent pipeline that powers the industry's future.

Georgia’s Life Sciences Momentum is Getting Noticed Nationally.

August 21, 2026
Genetic Engineering & Biotechnology News (GEN) has named Georgia #4 among its “Next 5 States” for emerging U.S. biopharma clusters . The article highlights UCB’s planned $2 billion investment at in Gwinnett County, Micron Biomedical’s new Alpharetta facility, Manus Bio’s expansion in Augusta, Science Square, Emory University, the CDC — and Georgia Life Sciences’ 10-year Life Sciences Roadmap . This recognition is exciting. But even more importantly, it validates the work happening across our entire ecosystem — and perfect momentum as we head into the 2026 Georgia Life Sciences Summit next week. Read more by visiting: Next 10 U.S. Biopharma Clusters

BIO Supports PDUFA VIII Commitment Letter and Urges Timely Reauthorization

August 17, 2026
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter: “For more than 30 years, PDUFA has helped deliver hundreds of new medicines to American patients. As a lead industry negotiator for the PDUFA VIII agreement, BIO supports the PDUFA VIII commitment letter and its strengthening of regulatory review, advancing innovation, and helping deliver safe and effective treatments to patients. “Specifically, the PDUFA VIII agreement includes important commitments that bolster the FDA’s core review activities, ensure accountability for predictable performance, improve financial sustainability and improve communication, transparency and efficiency. “Timely, bipartisan reauthorization of PDUFA is vital for protecting the health of Americans, strengthening U.S. competitiveness, and maintaining America’s global leadership in medical innovation. BIO is committed to working with Congress to ensure reauthorization by September 30, 2027.” The FDA has announced plans to hold a hybrid public meeting at 9am on 9/16 to discuss the proposed enhancements for the reauthorization of PDUFA for fiscal years (FYs) 2028 through 2033. Learn More about PDUFA and the PDUFA VIII commitment letter HERE .

Georgia Life Sciences Submits Comments on Medicare Drug Price Negotiation Program

August 17, 2026
Representing Georgia’s life sciences community, GLS emphasized the importance of advancing policies that improve affordability and patient access while preserving the environment necessary for continued biomedical innovation. In its comments, GLS urged CMS to maintain a framework grounded in FDA regulatory determinations and raised concerns about how certain proposed policies could affect post-approval research and development, investment in new indications, and patient access to innovative therapies. GLS also encouraged CMS to consider the broader implications for healthcare delivery, including the potential impact on patients and providers in rural and underserved communities. As federal drug pricing policy continues to evolve, Georgia Life Sciences will continue to advocate for approaches that balance affordability, access, and innovation while ensuring Georgia’s life sciences community has a voice in the policymaking process. Read Georgia Life Sciences’ full comments to CMS ( click here ).
MORE POSTS